Esther Poole

Esther Poole

Auto-generated profile, based on publicly available information

Esther Poole

Cardiac Services, Birmingham Children’s Hospital NHS Foundation Trust, Birmingham, UK

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2026 in Open Heart
Verified
Journal Article
Open access
PDF file
ATAbdulla Tarmahomed
Abdulla Tarmahomed
TBThomas W Binnersley
Thomas W Binnersley
CDCharlotte Davidson
Charlotte Davidson
ACAdrian Crucean
Adrian Crucean
EPEsther Poole
Esther Poole
RDRami Dhillon
Rami Dhillon
Objective: To compare long-term outcomes following balloon aortic valvuloplasty (BAV) and surgical aortic valvotomy (SAV), including surgical valvuloplasty for isolated severe congenital aortic valve stenosis (AVS). Data for mechanical aortic valve replacement and pulmonary autograft replacement are also presented to provide a complete institutional cohort overview. Methods: Retrospective single-centre cohort study including patients aged 65 mm Hg and/or mean gradient >40 mm Hg. Primary outcome was all-cause mortality. Secondary outcomes were time to reintervention and time to aortic valve replacement (AVR)—mechanical or autograft. Kaplan-Meier and Cox regression analyses were performed. Results: A total of 231 patients met inclusion criteria (96 BAV, 112 SAV, 23 other). Median age at intervention was lower in the SAV group (0.2 years vs 3.74 years, p<0.001). Overall survival was 99.4% at 10 years and 92.3% at 25 years, with no statistically significant difference between BAV and SAV (p=0.083), though a trend may exist. Reintervention occurred in 49% of patients overall, with similar rates between BAV and SAV (p=0.950). Freedom from mechanical or autograft AVR remained high (75% at 10 years; 67% at 25 years), with no significant difference between strategies (p=0.190). Neonatal intervention was associated with significantly lower freedom from reintervention (p<0.0001). Conclusions: Long-term survival following intervention for severe congenital AVS is excellent and comparable between BAV and SAV. Reintervention is common, particularly in neonates, but progression to AVR less so. These findings support continued multidisciplinary, anatomy-guided decision-making and highlight the importance of life-course management strategies. Development of a national AVS registry is indicated.